Your browser doesn't support javascript.
loading
Changes in older adults' life space during lung cancer treatment: A mixed methods cohort study.
Wong, Melisa L; Shi, Ying; Smith, Alexander K; Miaskowski, Christine; Boscardin, W John; Cohen, Harvey Jay; Lam, Vivian; Mazor, Melissa; Metzger, Lia; Presley, Carolyn J; Williams, Grant R; Loh, Kah Poh; Ursem, Carling J; Friedlander, Terence W; Blakely, Collin M; Gubens, Matthew A; Allen, Gregory; Shumay, Dianne; Walter, Louise C.
Afiliação
  • Wong ML; Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
  • Shi Y; Division of Geriatrics, University of California, San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
  • Smith AK; Division of Geriatrics, University of California, San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
  • Miaskowski C; Division of Geriatrics, University of California, San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
  • Boscardin WJ; Departments of Physiological Nursing and Anesthesiology and Perioperative Care, University of California San Francisco, San Francisco, California, USA.
  • Cohen HJ; Division of Geriatrics, University of California, San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
  • Lam V; Center for the Study of Aging & Human Development and Duke Cancer Institute, Duke University, Durham, North Carolina, USA.
  • Mazor M; Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
  • Metzger L; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Presley CJ; New York Medical College, Valhalla, New York, USA.
  • Williams GR; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Loh KP; Divisions of Hematology/Oncology & Gerontology, Geriatrics, and Palliative Care, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Ursem CJ; James P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA.
  • Friedlander TW; Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
  • Blakely CM; Division of Hematology-Oncology, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
  • Gubens MA; Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
  • Allen G; Division of Hematology-Oncology, Zuckerberg San Francisco General, San Francisco, California, USA.
  • Shumay D; Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
  • Walter LC; Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
J Am Geriatr Soc ; 70(1): 136-149, 2022 01.
Article em En | MEDLINE | ID: mdl-34611887
ABSTRACT

BACKGROUND:

Maintenance of function during cancer treatment is important to older adults. Characteristics associated with pretreatment life-space mobility and changes during non-small cell lung cancer (NSCLC) treatment remain unknown.

METHODS:

This mixed methods cohort study recruited adults age ≥65 with advanced NSCLC starting palliative chemotherapy, immunotherapy, and/or targeted therapy from a Comprehensive Cancer Center, Veterans Affairs, and safety-net clinic. Patients completed geriatric assessments including Life-Space Assessment (LSA) pretreatment and at 1, 2, 4, and 6 months after treatment initiation. LSA scores range from 0 to 120 (greater mobility); LSA <60 is considered restricted. We used mixed-effects models to examine pretreatment LSA, change from 0 to 1 month, and change from 1 to 6 months. A subgroup participated in semistructured interviews pretreatment and at 2 and 6 months to understand the patient experience of life-space change. For each interview participant, we created joint displays of longitudinal LSA scores juxtaposed with illustrative quotes.

RESULTS:

Among 93 patients, median age was 73 (range 65-94). Mean pretreatment LSA score was 67.1. On average, LSA declined 10.1 points from pretreatment to 1 month and remained stable at 6 months. Pretreatment LSA score was associated with several demographic, clinical, geriatric assessment, and symptom characteristics. LSA decline at 1 month was greater among patients with high anxiety (slope = -12.6 vs. -2.3, p = 0.048). Pretreatment body mass index <21 kg/m2 was associated with LSA improvement from 1 to 6 months (slope = 4.1 vs. -0.04, p = 0.003). Joint displays illustrated the impact of different life-space trajectories on patients' lives in their words.

CONCLUSION:

Older adults with NSCLC have low pretreatment life space with many developing restricted life space during treatment. Incorporating life-space assessments into clinical cancer care may help older adults concretely visualize how treatment might impact their daily function to allow for informed decision making and identify early changes in mobility to implement supportive interventions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atividades Cotidianas / Avaliação Geriátrica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atividades Cotidianas / Avaliação Geriátrica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article